Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phagocytic cell function in response to immunosuppressive therapy.

D B Drath, B D Kahan

    Archives of Surgery (Chicago, Ill. : 1960)
    |February 1, 1984
    PubMed
    Summary

    Immunosuppressive drugs used after kidney transplants primarily impair immune cell movement (chemotaxis), not their ability to engulf bacteria (phagocytosis) or release superoxide. These findings suggest a targeted impact on host defense mechanisms in lung immunity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nucleotide sequences of three distinct complementary DNA clones encoding rat class II major histocompatibility complex RT1.D beta-chain proteins.

    Immunogenetics·1999
    Same author

    Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.

    Transplantation proceedings·1999
    Same author

    Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein.

    Transplantation proceedings·1999
    Same author

    Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts.

    Transplantation proceedings·1999
    Same author

    Recommendations concerning the introduction of generic formulations of cyclosporine.

    Transplantation proceedings·1999
    Same author

    Considerations concerning generic formulations of immunosuppressive drugs.

    Transplantation proceedings·1999

    Area of Science:

    • Immunology
    • Pharmacology
    • Pulmonary Medicine

    Background:

    • Renal allograft recipients often experience increased pulmonary infections.
    • This is presumed to be linked to antirejection immunosuppressive therapy.
    • Understanding the impact of these therapies on lung immune cells is crucial.

    Purpose of the Study:

    • To assess immunosuppressive-related disturbances in lung immune responses.
    • To evaluate the functional abilities of pulmonary alveolar macrophages (PAMs) and polymorphonuclear leukocytes (PMNs).

    Main Methods:

    • Rats received cyclosporine, azathioprine, and/or prednisolone for 30 days.
    • Assays included chemotaxis, phagocytosis, and superoxide release.
    • Evaluated functional abilities of PAMs and PMNs.

    Related Experiment Videos

    Main Results:

    • None of the drugs affected superoxide release by stimulated PAMs or PMNs.
    • Phagocytosis of Staphylococcus aureus was largely unaffected, except for transient inhibition by azathioprine.
    • Cyclosporine inhibited PAM chemotaxis; azathioprine and prednisolone also impaired PAM and PMN chemotaxis.

    Conclusions:

    • Immunosuppressive agents largely spare nonspecific host defense elements, except for chemotaxis.
    • Cyclosporine, azathioprine, and prednisolone differentially affect immune cell function in the lung.
    • Findings highlight the specific impact on immune cell migration in immunosuppressed individuals.